The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 11,500.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 970.00 (8.435%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,370.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy

Mon, 11th May 2020 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

GOLDMAN SACHS CUTS NEXT TO 'NEUTRAL' ('BUY') - PRICE TARGET 5300 PENCE

----------

JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 8,000 (7,575) PENCE - 'HOLD'

----------

BRYAN GARNIER RAISES ASTRAZENECA PRICE TARGET TO 8,780 (8,550) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS EASYJET PRICE TARGET TO 746 (945) PENCE - 'OUTPERFORM

----------

MORGAN STANLEY CUTS LAND SECURITIES PRICE TARGET TO 740 (880) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS BRITISH LAND PRICE TARGET TO 450 (540) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES SEGRO PRICE TARGET TO 980 (950) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES CARNIVAL TO 'BUY' ('HOLD') - TARGET 1280 (3500) PENCE

----------

BERENBERG RAISES OCADO PRICE TARGET TO 2225 (1725) PENCE - 'BUY'

----------

BERENBERG RAISES ST JAMES'S PLACE PRICE TARGET TO 875 (830) PENCE - 'HOLD'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4560 (4730) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS BHP GROUP PRICE TARGET TO 1780 (1830) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ROLLS-ROYCE PRICE TARGET TO 155 (175) PENCE - 'UNDERWEIGHT'

----------

FTSE 250

----------

MORGAN STANLEY CUTS HAMMERSON TO 'UNDERWEIGHT' ('EQUAL-WEIGHT') - TARGET 50 (175) PENCE

----------

MORGAN STANLEY RAISES LONDONMETRIC PROPERTY TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 200 (210) PENCE

----------

MORGAN STANLEY CUTS SHAFTESBURY PRICE TARGET TO 610 (770) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY CUTS GREAT PORTLAND PRICE TARGET TO 720 (920) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS DERWENT LONDON PRICE TARGET TO 3400 (4250) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY CUTS BIG YELLOW GROUP PRICE TARGET TO 900 (1000) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES IMI PRICE TARGET TO 980 (940) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY CUTS UNITE GROUP PRICE TARGET TO 950 (1300) PENCE - 'OVERWEIGHT'

----------

UBS RAISES TRAVIS PERKINS PRICE TARGET TO 1070 (1040) PENCE - 'NEUTRAL'

----------

HSBC CUTS WEIR GROUP TO 'HOLD' ('BUY') - TARGET 985 (1045) PENCE

----------

JPMORGAN CUTS BODYCOTE PRICE TARGET TO 530 (615) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS TATE & LYLE PRICE TARGET TO 740 (770) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BERNSTEIN RAISES BOOHOO TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 415 PENCE

----------

BERENBERG CUTS AA PRICE TARGET TO 20 (30) PENCE - 'SELL'

----------

BERENBERG RAISES BURFORD CAPITAL PRICE TARGET TO 820 (810) PENCE - 'BUY'

----------

RBC CUTS SPIRE HEALTHCARE TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 100 PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.